These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7653914)

  • 21. A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene.
    Benson MD; Liepnieks JJ; Yazaki M; Yamashita T; Hamidi Asl K; Guenther B; Kluve-Beckerman B
    Genomics; 2001 Mar; 72(3):272-7. PubMed ID: 11401442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome.
    Holmgren G; Hellman U; Lundgren HE; Sandgren O; Suhr OB
    J Med Genet; 2005 Dec; 42(12):953-6. PubMed ID: 15930086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloidosis.
    Varga J
    J Med Soc N J; 1984 Mar; 81(3):248. PubMed ID: 6585571
    [No Abstract]   [Full Text] [Related]  

  • 25. Conformation preorganization: effects of S20G mutation on the structure of human islet amyloid polypeptide segment.
    Xu W; Jiang P; Mu Y
    J Phys Chem B; 2009 May; 113(20):7308-14. PubMed ID: 19402658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
    Sekijima Y; Dendle MT; Wiseman RL; White JT; D'Haeze W; Kelly JW
    Amyloid; 2006 Jun; 13(2):57-66. PubMed ID: 16911959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanism based on self-replicating protein conformation for the inheritance of acquired information in humans.
    Maury CP
    Med Hypotheses; 2006; 67(5):1164-9. PubMed ID: 16824696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological surfaces as catalysts of amyloid aggregate nucleation and primary sites of amyloid toxicity.
    Stefani M
    Ital J Biochem; 2006; 55(3-4):194-204. PubMed ID: 17274525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review: amyloidogenesis-unquestioned answers and unanswered questions.
    Kisilevsky R
    J Struct Biol; 2000 Jun; 130(2-3):99-108. PubMed ID: 10940218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis.
    Hamidi Asl K; Liepnieks JJ; Nakamura M; Parker F; Benson MD
    Biochem Biophys Res Commun; 1999 Apr; 257(2):584-8. PubMed ID: 10198255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
    Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
    J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils.
    Fu X; Korenaga T; Fu L; Xing Y; Guo Z; Matsushita T; Hosokawa M; Naiki H; Baba S; Kawata Y; Ikeda S; Ishihara T; Mori M; Higuchi K
    FEBS Lett; 2004 Apr; 563(1-3):179-84. PubMed ID: 15063745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trans-suppression of misfolding in an amyloid disease.
    Hammarström P; Schneider F; Kelly JW
    Science; 2001 Sep; 293(5539):2459-62. PubMed ID: 11577236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The workings of the amyloid diseases.
    Bellotti V; Nuvolone M; Giorgetti S; Obici L; Palladini G; Russo P; Lavatelli F; Perfetti V; Merlini G
    Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrilization in mouse senile amyloidosis is fibril conformation-dependent.
    Higuchi K; Kogishi K; Wang J; Chen X; Chiba T; Matsushita T; Hoshii Y; Kawano H; Ishihara T; Yokota T; Hosokawa M
    Lab Invest; 1998 Dec; 78(12):1535-42. PubMed ID: 9881953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [From the protein to amyloid deposit].
    Delpech M
    Rev Med Interne; 2001 Jun; 22 Suppl 1():8s-9s. PubMed ID: 11439443
    [No Abstract]   [Full Text] [Related]  

  • 37. Amyloids and other abnormal assembly processes, FASEB Summer Conference, Copper Mountain, Colorado, June 11-16, 2000.
    Fraser P
    Amyloid; 2001 Dec; 8(4):285-90. PubMed ID: 11791623
    [No Abstract]   [Full Text] [Related]  

  • 38. The nature and origin of amyloid fibrils. Proceedings of a symposium. Oeiras, Portugal, 23-25 October 1995.
    Ciba Found Symp; 1996; 199():1-253. PubMed ID: 8915600
    [No Abstract]   [Full Text] [Related]  

  • 39. Are cheetahs on the run from prion-like amyloidosis?
    Caughey B; Baron GS
    Proc Natl Acad Sci U S A; 2008 May; 105(20):7113-4. PubMed ID: 18487456
    [No Abstract]   [Full Text] [Related]  

  • 40. Amyloidosis: a universal disease of aging?
    Blumenthal HT
    J Gerontol A Biol Sci Med Sci; 2004 Apr; 59(4):361-9. PubMed ID: 15071080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.